LeadIQ logo
Learn more at LeadIQ.com

Insights

Strategic Partnership with Amgen Arrakis Therapeutics has recently partnered with Amgen, a collaboration that could potentially be worth several billion dollars. This partnership opens up opportunities to explore RNA degrader therapeutics against challenging drug targets in multiple therapeutic areas, presenting a significant sales opportunity for the company.

Hiring Key Personnel Arrakis Therapeutics has strategically onboarded key personnel, such as James Mutamba as Chief Business Officer, and Adrian Whitty to its Scientific Advisory Board. These additions indicate a focus on building a strong team, which can drive sales growth through expertise in RNA-focused drug discovery and development.

Revenue and Funding With a revenue range of $10-50 million and funding of $75 million, Arrakis Therapeutics showcases financial stability and potential for investment. This financial health positions the company to invest in innovative research and development, creating opportunities for revenue growth and sales expansion.

Focus on RNA-targeted Medicines Arrakis Therapeutics is pioneering the discovery of small-molecule medicines that directly target RNA, a cutting-edge area in pharmaceuticals. By focusing on RNA biology in new ways and targeting previously 'undruggable' targets, the company has the potential to impact millions of patients, presenting a unique selling point in the market.

Competitive Landscape By analyzing similar companies in the pharmaceutical industry, Arrakis Therapeutics can identify potential competitive advantages and market differentiators. Understanding the landscape with companies like Clovis Oncology, Schrödinger, and Syros Pharmaceuticals can provide insights for strategic positioning and targeted sales efforts.

Similar companies to Arrakis Therapeutics

Arrakis Therapeutics Tech Stack

Arrakis Therapeutics uses 8 technology products and services including Cloudflare, jQuery Migrate, Open Graph, and more. Explore Arrakis Therapeutics's tech stack below.

  • Cloudflare
    Content Management System
  • jQuery Migrate
    Javascript Libraries
  • Open Graph
    Miscellaneous
  • Microsoft
    Miscellaneous
  • Google
    Miscellaneous
  • Linux
    Programming Languages
  • Microsoft Exchange
    Storage
  • Smash Balloon Instagram Feed
    Web Platform Extensions

Media & News

Arrakis Therapeutics's Email Address Formats

Arrakis Therapeutics uses at least 1 format(s):
Arrakis Therapeutics Email FormatsExamplePercentage
FLast@arrakistx.comJDoe@arrakistx.com
95%
Last@arrakistx.comDoe@arrakistx.com
3%
FMLast@arrakistx.comJMDoe@arrakistx.com
1%
First.Last@arrakistx.comJohn.Doe@arrakistx.com
1%

Frequently Asked Questions

Where is Arrakis Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Arrakis Therapeutics's main headquarters is located at 828 Winter Street Waltham, MA 02451 US. The company has employees across 4 continents, including North AmericaEuropeAfrica.

What is Arrakis Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Arrakis Therapeutics's official website is arrakistx.com and has social profiles on LinkedIn.

How much revenue does Arrakis Therapeutics generate?

Minus sign iconPlus sign icon
As of October 2024, Arrakis Therapeutics's annual revenue reached $35M.

What is Arrakis Therapeutics's NAICS code?

Minus sign iconPlus sign icon
Arrakis Therapeutics's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Arrakis Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2024, Arrakis Therapeutics has approximately 86 employees across 4 continents, including North AmericaEuropeAfrica. Key team members include Chief Executive Officer: M. G.Chief Business Officer: J. M.Chief Business Officer: D. K.. Explore Arrakis Therapeutics's employee directory with LeadIQ.

What industry does Arrakis Therapeutics belong to?

Minus sign iconPlus sign icon
Arrakis Therapeutics operates in the Pharmaceutical Manufacturing industry.

What technology does Arrakis Therapeutics use?

Minus sign iconPlus sign icon
Arrakis Therapeutics's tech stack includes CloudflarejQuery MigrateOpen GraphMicrosoftGoogleLinuxMicrosoft ExchangeSmash Balloon Instagram Feed.

What is Arrakis Therapeutics's email format?

Minus sign iconPlus sign icon
Arrakis Therapeutics's email format typically follows the pattern of . Find more Arrakis Therapeutics email formats with LeadIQ.

How much funding has Arrakis Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2024, Arrakis Therapeutics has raised $75M in funding. The last funding round occurred on Apr 18, 2019 for $75M.

When was Arrakis Therapeutics founded?

Minus sign iconPlus sign icon
Arrakis Therapeutics was founded in 2015.
Arrakis Therapeutics

Arrakis Therapeutics

Pharmaceutical ManufacturingMassachusetts, United States51-200 Employees

Arrakis has a simple but powerful vision: To extend small-molecule medicines into new realms of biology, unlocking that biology for medicine. Our approach builds on the existing sophisticated drug discovery toolkit developed for protein targets, which we are adapting and refocusing on discovering small-molecule compounds that act directly on RNA.

We are pioneering new territory, with an expedition led by a team of skilled scientists and drug development leaders who are inventive yet pragmatic. We are on a bold and exciting mission, a mission not without peril, but we have an energized, collaborative, creative and fearless team – a team that has consistently breached barriers and blazed new trails in search of solutions. We are now poised to realize the promise of bringing RNA into play for small-molecule drug discovery.

Pushing the frontier of this emerging field of science is gratifying, but our mission goes beyond the thrill of scientific discovery.  We believe that by targeting RNA biology in new ways, we have the potential to impact millions of patients.  Our platform will allow us to reach hundreds of biological targets not currently accessible to medicine, including known targets previously considered “undruggable.” Our destination is powerful new therapies for patients everywhere, by opening up a new path for discovering RNA-targeted medicines.

Section iconCompany Overview

Headquarters
828 Winter Street Waltham, MA 02451 US
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $75M

    Arrakis Therapeutics has raised a total of $75M of funding over 2 rounds. Their latest funding round was raised on Apr 18, 2019 in the amount of $75M.

  • $10M$50M

    Arrakis Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $75M

    Arrakis Therapeutics has raised a total of $75M of funding over 2 rounds. Their latest funding round was raised on Apr 18, 2019 in the amount of $75M.

  • $10M$50M

    Arrakis Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.